Use of Cangrelor as a Bridge to Left Ventricular Assist Device Implantation in a Patient with a Recent Drug‐Eluting Stent Who Developed Acute Tirofiban‐Related Thrombocytopenia
Rajiv A. Kabadi(Thomas Jefferson University Hospital), Ataul Qureshi(Thomas Jefferson University), Andrew Boyle(University of Miami), Gordon R. Reeves(Thomas Jefferson University), Gregary Marhefka(Thomas Jefferson University Hospital), Ilya Danelich(AstraZeneca (South Korea)), John W. Entwistle(Thomas Jefferson University Hospital)
Cited by 5
Related Papers
Time to Anticoagulation Reversal and Outcomes After Intracerebral Hemorrhage
|JAMA Neurology|2024|88
Practical Management of Postoperative Atrial Fibrillation after Noncardiac Surgery
|Journal of the American College of Surgeons|2014|73
Safety of Nonsteroidal Antiinflammatory Drugs in Patients with Cardiovascular Disease
|Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy|2015|55
Role of clinical pharmacists and pharmacy support personnel in transitions of care
|JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY|2020|40
Impact of the Pharmacy Practice Model Initiative on Clinical Pharmacy Specialist Practice
|Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy|2016|29